Advanced Biomed Inc. Common Stock
ADVB
NASDAQ·Healthcare·Medical - Diagnostics & Research·Mkt cap $12.9M
$9.34
▼ -0.69%
P/E
-83.35
Mkt Cap
$12.9M
52-Wk Range
$3.61–$24.23
52-Week Range
$3.61 - $24.23
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 8.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary microfluidic biochip technology platform
- Comprehensive CTC detection and analysis capabilities
- Specialized immunochromogenic kit portfolio for multiple tumor cell types
- Established presence in high-growth Asian markets
Bear Case
1 risk
- Low volatility (beta -0.4).
Growth
No forward estimates available
Rising global demand for precision oncology diagnostics
Value
Valuation data unavailable
Momentum
Hot
+136.9% over 3m
Quality
Loss-making
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying ADVB right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Most recent quarter reported revenue of $0. Reported EPS of -$0.38.
Reported EPS · last 4Q
Q3 26
-$0.38
Q2 25
$0.31
Q1 25
-$0.02
Q4 25
-$0.02
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q4 24
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q3 26
$0
$0
$0
$0
$0
$0
$0
$0
Margins · last 8Q
No margin history available.
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How ADVB stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related